Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Accumulated Depreciation & Amortization (2016 - 2025)

Fortress Biotech (FBIO) has 12 years of Accumulated Depreciation & Amortization data on record, last reported at $12.1 million in Q4 2024.

  • For Q4 2024, Accumulated Depreciation & Amortization rose 36.17% year-over-year to $12.1 million; the TTM value through Dec 2024 reached $12.1 million, up 36.17%, while the annual FY2024 figure was $12.1 million, 36.17% up from the prior year.
  • Accumulated Depreciation & Amortization reached $12.1 million in Q4 2024 per FBIO's latest filing, up from $12.0 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $13.3 million in Q1 2023 and bottomed at $5.0 million in Q1 2020.
  • Average Accumulated Depreciation & Amortization over 5 years is $9.3 million, with a median of $9.3 million recorded in 2024.
  • Peak YoY movement for Accumulated Depreciation & Amortization: soared 59.59% in 2020, then tumbled 30.26% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $6.8 million in 2020, then soared by 38.84% to $9.4 million in 2021, then soared by 32.49% to $12.4 million in 2022, then decreased by 28.56% to $8.9 million in 2023, then surged by 36.17% to $12.1 million in 2024.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $12.1 million in Q4 2024, $12.0 million in Q3 2024, and $11.8 million in Q2 2024.